Clinical Trial Update: Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial [Phase 4]

View source ↗

Summary

Phase 4 OPTIMIZE trial investigates proactive dosing optimization of infliximab in inflammatory bowel disease using a pharmacokinetic dashboard versus standard …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Crohn Disease, Ulcerative Colitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING